The Board of Directors of the GlaxoSmithKline Pharmaceuticals Limited at its meeting held 17th October 2022, has appointed Mr. Bhushan Akshikar as a Managing Director of the Company for period of four years effective 1st December 2022. He succeeds Mr. Sridhar Venkatesh who is moving to a new senior role within GSK Group effective 1st December 2022. The Company places on record its appreciation for the guidance and support provided by Mr. Sridhar Venkatesh during his tenure.

Bhushan joined GSK India in September 2011 to lead the specialty and commercial excellence business units. In 2014, he was appointed Head of the Mass Markets business. He was subsequently elevated as the Managing Director of the publicly listed entity of GSK in Nigeria, Africa in end- 2016.

Apart from a strong business turn-around, he also built a high performing, resilient team . He then moved to Turkey in 2019 to lead GS K's Vaccines business to drive strategic initiatives and launches in both private and tender segments in the Middle East, Russia CIS & Africa region . In December 2020 he returned to India as the Commercial Head of the General Medicines business and has led a cultural transformation journey for the large INR 25,000+ million General Medicines business.

He has built a strong leadership pipeline reflecting in leadership position and improved competitive performance of several brands of GSK. Before joining GSK, Bhushan spent 15 years with Janssen, Johnson & Johnson in various roles leading both specialty and primary care business units in local and regional positions living in India, S Korea and Belgium. Bhushan holds a post graduate MBA in Marketing from SPJIMR and a Bachelor's Degree in Pharmaceutical sciences from University of Pune.

Bhushan is married and has two sons.